News

In Japan, Lenvima is the first molecular targeted treatment approved with an indication for unresectable thyroid cancer which covers differentiated thyroid cancer as well as medullary thyroid carcinoma

This study demonstrated that Latuda (lurasidone HCl) significantly reduced depressive symptoms in adults with MDD with mixed features when compared to placebo. The study results were presented at

The Muscle Maker Grill booster supplements are intended to meet the growing consumer demand for customized smoothies and protein shakes as well as help Muscle Maker Grill franchisees

"Emergent is pleased to enter into this agreement, which reflects our leading capabilities in plasma fractionation and fits perfectly with ProMetic’s proprietary plasma purification platform," said Barry Labinger,

Under the agreement, DNAtrix will utilize Alcyone’s MEMS Cannula (AMC) targeted delivery platform for the intratumoral delivery of DNX-2401, an oncolytic adenovirus and DNAtrix’s lead product for the

A significant percentage ofobese patients do not progress to full cure after antibiotictreatment is completed. Among obese patients whose infection wasnot fully cured at late follow-up, health-related quality

Under the deal, the OCTC will provide integrated research, clinical trial and core lab services, while Bryla will provide commercialization services in chemistry, manufacturing and control (CMC). Bryla

The trial is designed to evaluate the safety, pharmacokinetics (PK) and efficacy of GMI-1271 when used in combination with chemotherapy in AML patients. Initially, the company is exploring

The initiation of this Phase III trial follows a Phase II trial, which showed positive results in slowing cognitive decline with 5mg/day of azeliragon in patients with mild